
Portfolio

M&A
miRagen Therapeutics, Inc.
Company website
Category
Development of nuclid acid therapeutics targeting microRNAs
Initial investment
2015M&A
miRagen Therapeutics, Inc.
Company website
Category
Development of nuclid acid therapeutics targeting microRNAs
Initial investment
2015